Cleo Diagnostics Ltd (ASX: COV) — Healthcare · Share Price, Chart & Market Data
About: Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$0.63 (-8.09%)
COVCleo Diagnostics Ltd
Loading watchlist status…
Trade COV now
Cleo Diagnostics Ltd share price
COV price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:01 am GMT+0
COV price performance
6.838%
5D
23.762%
1M
1.626%
YTD
56.25%
1Y
COV price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:01 am GMT+0
COV details
COV Market Signals